VKTX Viking Therapeutics, Inc.

NASDAQ
$31.53

Viking Therapeutics, Inc. (VKTX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with VKTX's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
5
20 transactions
Purchases
$149.9K
4,475 shares
Sales
$22.3M
664,041 shares
Net activity
-$22.1M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $22.3M 20 transactions · 664,041 shares

Largest single sale: $4.9M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: March 10, 2026 , by Aubuchon Neil William .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Lian Brian President & CEO Sell 148,517 $33.32 $4.9M 2,572,441 −5.5% of holding
ZANTE GREG Chief Financial Officer Sell 21,217 $33.47 $710.1K 212,204 −9.1% of holding
Mancini Marianna Chief Operating Officer Sell 18,217 $33.47 $609.6K 422,760 −4.1% of holding
Aubuchon Neil William Chief Commercial Officer Buy 4,475 $33.50 $149.9K 4,475
Lian Brian 4 fills President & CEO Sell 233,409 $32.96 $7.7M 2,600,246 −8.2% of holding
Mancini Marianna 4 fills Chief Operating Officer Sell 57,661 $32.98 $1.9M 434,890 −11.7% of holding
ZANTE GREG 4 fills Chief Financial Officer Sell 57,661 $32.90 $1.9M 215,571 −21.1% of holding
FOEHR MATTHEW W Director Sell 16,000 $35.11 $561.7K 132,036 −10.8% of holding
Lian Brian President & CEO Sell 38,989 $35.01 $1.4M 2,419,109 −1.6% of holding
Mancini Marianna Chief Operating Officer Sell 6,185 $35.00 $216.5K 382,467 −1.6% of holding
ZANTE GREG Chief Financial Officer Sell 6,185 $35.00 $216.5K 173,592 −3.4% of holding
Rowland Charles A Jr Director Sell 60,000 $35.57 $2.1M 30,000 −66.7% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.